Not Medicare Enrolled

Dr. Fred Ghali, MD

Dermatology · Grapevine, TX
Speaking/Promotional
1325 W NORTHWEST HWY, Grapevine, TX 76051
8174213376
In practice since 2006 (19 years)
NPI: 1639286339 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ghali from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ghali? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ghali

Dr. Fred Ghali is a dermatology specialist in Grapevine, TX, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Ghali received a total of $538,024 from 38 pharmaceutical and/or device companies across 1230 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ghali is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice $538,024 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$538,024
Total received (2018-2024)
Avg $76,861/year across 7 years
Top 2% in TX for dermatology
38
Companies
1,230
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$453,414 (84.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$75,281 (14.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,328 (1.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$94,280
2023
$72,619
2022
$67,942
2021
$37,074
2020
$95,872
2019
$116,867
2018
$53,370

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GENZYME CORPORATION
$206,247
Regeneron Healthcare Solutions, Inc.
$113,366
Galderma Laboratories, L.P.
$57,956
SANOFI-AVENTIS U.S. LLC
$48,547
Dermavant Sciences, Inc.
$25,979
Ortho Dermatologics, a division of Bausch Health US, LLC
$18,155
PFIZER INC.
$15,722
Regeneron Pharmaceuticals, Inc.
$11,089
NOVARTIS PHARMACEUTICALS CORPORATION
$9,091
Arcutis Biotherapeutics, Inc.
$6,726
AbbVie, Inc.
$5,388
Incyte Corporation
$4,125
EPI Health, LLC
$3,757
Almirall LLC
$2,527
ABBVIE INC.
$2,392
Pierre Fabre Pharmaceuticals, Inc.
$1,276
Verrica Pharmaceuticals Inc.
$1,217
Lilly USA, LLC
$913
Novartis Pharmaceuticals Corporation
$740
Sun Pharmaceutical Industries Inc.
$505
MAYNE PHARMA INC.
$404
AbbVie Inc.
$289
Mayne Pharma Inc.
$277
MAYNE PHARMA COMMERCIAL LLC
$236
Krystal Biotech Inc
$224
Amgen Inc.
$218
SUN PHARMACEUTICAL INDUSTRIES INC.
$181
LEO Pharma Inc.
$89
Taro Pharmaceuticals USA, Inc.
$57
Celgene Corporation
$57
Allergan Inc.
$48
Biofrontera Inc.
$45
Mylan Pharmaceuticals Inc.
$45
NOBELPHARMA AMERICA, LLC
$33
DERMIRA, INC.
$31
Alexion Pharmaceuticals, Inc.
$25
Medimetriks Pharmaceuticals, Inc.
$24
Journey Medical Corporation
$22
Top 3 companies account for 70.2% of total payments
Associated products mentioned in payments ›
0.25% · ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · AKLIEF · ARAZLO · Absorica LD · Acticlate · Aczone · Ameluz · BOTOX · CIBINQO · COSENTYX · Cabtreo · Clindacin ETZ · Clindamycin Phosphate and Benzoyl Peroxide · Cordran · DERMATITIS - DISEASE · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EBGLYSS · ELIDEL · EPIDUO FORTE · EPSOLAY · EUCRISA · Enbrel · HALOG (Halcinonide Cream · HALOG OINTMENT (Halcinonide Ointment · HUMIRA · HYFTOR · Humira · JUBLIA · Klisyri · LITFULO · NO PRODUCT DISCUSSED · ONEXTON · OPZELURA · ORACEA · Olux · Otezla · QBREXZA · RETIN-A-MICRO · RINVOQ · SEYSARA · SILIQ · SKYRIZI · SOOLANTRA · Seysara · Sitavig · TALTZ · TAPINAROF · TOPICORT (desoximetasone) Topical Spray · TWYNEO · ULTRAVATE (halobetasol propionate) lotion · USP) 0.1% · VTAMA · VYJUVEK · Veltin · Winlevi · Xolegel · YCANTH · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (84%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in dermatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for dermatology in TX.

Looking for a dermatology specialist in Grapevine?
Compare dermatologists in the Grapevine area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
225
Per 100K population
10.5
County median income
$81,905
Nearest hospital
BAYLOR SCOTT & WHITE MEDICAL CENTER GRAPEVINE
0.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ghali is a dermatology specialist, with speaking/promotional industry engagement in the top 2% of TX peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Ghali receive payments from pharmaceutical companies?
Yes. Dr. Ghali received a total of $538,024 from 38 companies across 1,230 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Ghali) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Dermatologists in Grapevine
Browse dermatologists in Grapevine ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in TX
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in TX
Which TX dermatologists receive the most from drug and device companies.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
By company
Galderma Laboratories, L.P. Payments to Doctors
See all physicians who received payments from Galderma Laboratories, L.P.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →